Advertisement

Topics

Lundbeck says Alzheimer's drug fails in late-stage study

11:35 EDT 22 Sep 2016 | Reuters

(Reuters) - Danish drugmaker H Lundbeck A/S's highly anticipated experimental Alzheimer's drug failed in a late-stage study, underscoring the challenges faced by drugmakers to tackle the debilitating memory-robbing disease.

Original Article: Lundbeck says Alzheimer's drug fails in late-stage study

NEXT ARTICLE

More From BioPortfolio on "Lundbeck says Alzheimer's drug fails in late-stage study"

Quick Search
Advertisement
 

Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...